PMGC secures five-year royalty payment plan from Elevai Skincare sale through August 2031

Bitget2026/09/18 12:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

PMGC Holdings entered an interest-bearing payment agreement with Longevity Health Holdings to secure royalty payments tied to its January 2025 sale of the Elevai Skincare business.
The deal converts a 5% net sales royalty into scheduled monthly payments of $10,000 starting Oct. 15, 2026, with all amounts due by Aug. 28, 2031.
Longevity acknowledged a 2025 royalty payable of USD 94,937, with interest at the Wall Street Journal Prime Rate plus 1% from the original April 2026 due date.
Future royalty and earnout amounts will roll into the same payment plan, with mandatory prepayments triggered by certain capital events.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMGC Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609180800PRIMZONEFULLFEED9829366) on September 18, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PMGC secures five-year royalty payment plan from Elevai Skincare sale through August 2031

You may also like

Crypto prices